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Abstract
Background: Epidemiological studies have assessed relationships between circulating levels of fatty acid (FA) and
blood pressure (BP), and their results remain controversial. Nevertheless, data are sparse on serum FA as biomarker
and BP in China. The aim of the study was to investigate the association between serum FA and BP in Chinese
populations.
Methods: We conducted a cross-sectional study nested within a community-based cohort of 2447 Chinese
participants aged 35–79 years who completed a baseline assessment between October 2012 and April 2013.
Baseline assessment included the collection of fasting blood samples, anthropometric measurements and a
personal interview using a validated questionnaire. Serum FA was determined by gas-liquid chromatography.
Exploratory factor analyses were employed to identify FA-factor as a reflection of serum FA pattern. A multiple
regression model was conducted to estimate adjusted mean of BP with 95 % confidence interval (CI) by tertile
groups of the generated FA-factor scores.
Results: Hypertensive patients have significantly higher serum 14:0, 16:0, 16:1n-7, 18:3n-6, 20:3n-6 and Δ6-desaturase
index (18:3n-6/18:2n-6) as well as lower 18:2n-6, 22:6n-3 and Δ5-desaturase index (20:4n-6/20:3n-6) compared with
normotensive participants. Factor 1 (low linoleic acid/high saturated FA pattern: 14:0, 16:0, 16:1n-7, 18:2n-6, 18:3n-6,
20:3n-6) and Factor 2 (n-3 PUFA pattern: 20:5n-3, 22:5n-3, 22:6n-3, 18:1n-9) were identified as indicators of the
serum FA pattern. After adjustment for age, gender, body mass index, hypertension treatment, smoking, alcohol
intake, education, profession, exercise habit, salt intake, family history of hypertension, heart rate, blood lipids and
fasting blood-glucose levels, per a standard deviation (SD) increment of Factor 1 scores was associated with an
increment of 2.44 (95 % CI: 1.73, 3.15) mm Hg for systolic BP, whereas per a SD increment of Factor 2 scores was
associated with a reduction of 1.40 (95 % CI: 0.80, 2.04) mm Hg for diastolic BP.
Conclusions: The serum FA pattern characterized by low proportions of 14:0, 16:0, 16:1n-7 and 18:3n-6 as well as high
18:2n-6 and 22:6n-3 was beneficially associated with BP levels in this Chinese population. This evidence well supports
the current dietary recommendations in the communities to replace saturated fat with polyunsaturated fat.
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Background
Adverse blood pressure (BP) levels remain a major
public-health problem worldwide, and almost 2.11 mil-
lion cardiovascular deaths are attributable to greater BP
in China annually [1]. Data from meta-analyses [2, 3]
and clinical trials [4, 5] have suggested that n-3 polyun-
saturated fatty acid (PUFA) supplement can dose-
dependently lower BP in hypertensive patients but not
in normotensive individuals. A large-scale, population-
based International Study of Macro/Micronutrients and
Blood Pressure (INTERMAP) suggested that dietary in-
take of n-3 PUFA was inversely associated with BP levels
in middle-aged normotensive persons [6]. However, its
potential limitations are likely to be dietary measure-
ment errors or bias with consequent limited ability to
classify dietary intake of individuals accurately and
underestimation of effect size attributable to limited reli-
ability in dietary estimations.
In contrast to dietary questionnaires, FA levels in circu-
lating blood can provide objective measures that reflect
both dietary consumption and relevant biological pro-
cesses. Additionally, FA biomarker can also permit direct
evaluation of individual FA that may have different effects
on certain biological pathways or clinical end points. Ex-
amples of this have been reported that circulating levels of
PUFA were significantly correlated with intake of polyun-
saturated fat [7], while circulating levels of 14:0, 16:0, 18:0
and monounsaturated FA (MUFA) may reflect a diet rich
in saturated fat, because of their high correlations with
saturated fat [8]. Prior observational studies examined as-
sociations between serum/plasma FA as biomarker and
BP, and their finding were controversial [9–11]. Possible
reasons for the inconsistencies across studies may be BP
measurements insufficiently standardized and small sam-
ple sizes with a low statistical power. Recently, a large-
scale longitudinal study of erythrocyte FA in relation to
BP change in 1834 middle-aged and elderly Chinese indi-
viduals indicated that erythrocyte long-chain (LC) n-3
PUFA was associated reduced BP levels of individuals
[12]. However, the small changes in BP and relatively great
errors in BP measurements during follow-up would sub-
stantially attenuate the FA-BP associations. Additionally,
the amount of each FA is often expressed as a proportion
and is a relative measure, which means that many of indi-
vidual FA are inter-related. A change in the proportion of
any specific FA will influence the proportions of several
others in blood, which was likely to bias the true associ-
ation between individual FA and BP. Thus, the association
between circulating levels of FA as biomarker and BP of
individuals merit further study.
We therefore attempted to employ a method of ex-
ploratory factor analyses to identify the specific FA-
factors as an indicator of FA patterns [13]. Totally, 2447
community-dwellers (1153 males and 1294 females)
aged 35–79 years living in Zhejiang Province, southeast
China were recruited through a cross-sectional study
nested with in a community-based cohort. The aim of
the study was to investigate the association between




The cross-sectional study with baseline data was con-
duced within a community-based cohort (Zhejiang Pro-
spective Investigation into Hypertension and Lifestyle,
ZPIHL). The study protocol was approved by the Ethics
Committee, Zhejiang Hospital, China. All subjects pro-
vided their written consent prior to participation in the
study. The detailed methods for participant selection are
presented elsewhere [14]. Briefly, study participants were
recruited from 6 community health centers across 12
counties located in Zhejiang Province, southeast China.
Zhejiang province is a well development region with a
good medicare system even in remote areas. Totally, 3,500
individuals aged 35–79 years were invited between April
and October 2012. Participants are all local Chinese resi-
dents, and their complete healthy/medical records were
documented in the local community hospitals. To define
study participants, we excluded anyone who has no
complete medical record, and meet any of the following
items: myocardial infarction, coronary heart disease, per-
ipheral vascular disease, angina, cancer, dementia, schizo-
phrenia, deaf or dumb, < 35 years, less than 6 months of
living in the local communities. Finally, 3,017 participants
with complete health records agreed to participate in the
study. Baseline assessment included the collection of fast-
ing blood samples, anthropometric measurements and a
personal interview using a validated questionnaire about
medical history, socio-demographic and lifestyle charac-
teristics between October 2012 and April 2013. Of those,
2,535 subjects provided fasting blood samples and com-
pleted a laboratory assessment, with a participation rate of
84.02 % (2535/3017). Subjects with missing values (n = 56)
or implausible data (n = 19) on lifestyle factors from the
structured questionnaire and with unreliable data on
serum FA (n = 13) were excluded. Afterwards, 2,447 par-
ticipants (1,153 males and 1,294 females) were finally
remained for baseline analyses.
Questionnaire interview
A face-to-face interview was conducted by trained inter-
viewers using a validated questionnaire. We collected
data on socio-demographic, medical history, and lifestyle
factors. Education levels were categorized as primary
(duration of education < 9 years), secondary (9–12 years)
and high (>12 years). High-salt intake was defined as salt
consumption with > 6 g per day [15]. Regular exercisers
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were those who sported ≥ 3 times per week for over
6 months. Current smokers were those who smoked ≥18
packs per year, while current drinkers were those who
consumed alcoholic beverage ≥ 25 g per day.
Measurements of anthropometric parameters and blood
pressure
Anthropometrical measurements were performed by
trained nurses using standard protocols. Body weight
(kg) and height (m) were measured with participants
wearing no shoes and light clothing. Body mass index
(BMI) was calculated as the participant’s weight (kg) di-
vided by the square of standing height (m). Before heart
rate (HR, beat/min) and blood pressure (BP, mm Hg)
measurements, participants were advised to avoid con-
suming alcohol or tobacco, ingesting tea or coffee, and
engaging in exercise for at least 30 min. A standardized
mercury sphygmomanometer was used to measure BP
by trained physicians, and one of three cuff sizes (regular
adult, large or thigh) was chosen based on the circum-
ference of the participant’s arm. BP and HR for each
subject were defined as the average of three measure-
ments performed in the subject in sitting position with
2-min intervals at that visit. Prevalent hypertension was
ascertained by meeting 1 of 2 criteria: (a) a new phys-
ician diagnosis of hypertension (an average systolic BP
(SBP) ≥ 140 mm Hg and/or an average diastolic BP
(DBP) ≥ 90 mmHg); or (b) self-reported treatment of
hypertension with anti-hypertensive drugs.
Laboratory assessment
Fasting blood samples were collected in tubes with
serum separator gel. They were left at room temperature
for 30 min and then centrifuged at 2500 RCF (g) for 15
mins to isolate serum. Measurement of fasting serum
triglycerides (TG), total cholesterol (TC) and glucose
(Fbg) levels were determined by standard procedures at
the biochemistry laboratory of Zhejiang Hospital. The
remaining serum samples were aliquoted into separate
tubes (1 mL) and stored at -80 0C until further FA
analyses.
Frozen samples were thawed on ice for 40 mins. The
total lipid content of the serum was extracted with sol-
vents. The methyl esters of FA in serum were prepared by
saponification, and serum compositions of FA were deter-
mined by gas-liquid chromatography (GLC) as described
previously [16]. The main sources of serum FA are derived
from cholesterol esters, phospholipids, and triglycerides.
The amount of individual FA was expressed as a percent-
age of total FA in serum.
Statistical analysis
Statistical analyses of all the data were performed by
STATA version 11.0 (Stata CORP, College Station, TX).
Descriptive statistics was initially conducted. The distri-
bution of continuous variables was examined for nor-
mality by Shapiro-Wilk’s test. Continuous data with the
normal distribution were expressed as the mean (stand-
ard deviation), while categorical data were expressed as
a proportion. The skewed data were expressed as the
median (quartile range), and were log-transformed be-
fore statistic analyses. Difference in the continuous and
categorical variables between two groups was examined
by Student’s t-test and chi-square test, respectively. Fac-
tor analysis has been a multivariate statistical tool of
dimension-reduction to study FA patterns [13], which
can be performed to address inter-relations between in-
dividual FA content. Individual FA was entered in a fac-
tor analysis model followed by variance rotation to
identify the specific FA-factors as a measure of FA pat-
tern. The resulting FA-factor pattern was determined by
a factor loading, the eigenvalue and the explained
proportion of total variance. Factor loading of each indi-
vidual FA equals the Pearson correlation coefficient be-
tween that FA and the generated FA-factor. Factor
loading with ≥ |0.40| were considered meaningful for the
interpretation of FA-factor [17]. Eigenvalue described
the amount of variance attributable to the FA-factors.
The powerful FA-factors with eigenvalue > 1 were ex-
tracted for further analyses, which explained more than
70 % of the total variance. Factor scores for each FA pat-
tern can be calculated as a sum of the products of factor
loading coefficients and the standardized each FA corre-
lated with that FA pattern. To determine if serum FA
patterns were associated with BP levels, a multiple re-
gression model was conducted to estimate adjusted
mean of BP with 95 % confidence interval (CI) by tertile
groups of the generated FA-factor scores. The ordinal
numbers 0–2 was assigned to the tertile (T) categories
of FA-factor scores, and then a linear trend test was per-
formed by treating the ordinal score variable as a con-
tinuous variable in the models. The dependent variables
(SBP and DBP), biochemical parameters (TC, TG, and
Fbg levels) and anthropometrical data (HR and BMI)
were continuous, while socio-demographic (age (≤55,
>55), gender, profession (manual, non-manual), and edu-
cation levels), lifestyle data (smoking habit (current,
former/never), alcohol consumption (current, former/
never), high-salt diet (yes, no)) and family history of
hypertension (yes, no) as the independent variables were
categorical. Initial model was adjusted for age, gender,
BMI and hypertension treatment; model 1 was adjusted
for the covariates in model 1 plus lifestyle factors; model
2 as a full model was adjusted for the covariates in
model 2 plus clinical parameters (family history of
hypertension, TC, TG, HR and Fbg levels). In addition,
to test the robustness of the findings from factor ana-
lyses, a multiple regression analysis was repeated to
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assess associations of individual FA contributing most to
FA-factors with BP levels. All statistic tests were two-




Totally, 748 hypertensive patients were identified from
2447 community-dwellers aged 35–79 years who com-
pleted baseline measurements. Characteristics of study
participants according to BP status are presented in
Table 1. All participants are comprised of 1153 males
(47.12 %) and 1294 females (52.88 %). The proportion of
prevalent hypertension was significantly higher in 1,201
middle-aged than in 1,246 elderly participants. Hyper-
tensive patients likely tended to have primary education
levels, non-manual labor, high-salt diet, irregular/never
sporters, family history of hypertension, higher BMI, BP,
HR, TG, TC and Fbg levels compared with normotensive
participants (all P < 0.05).
Serum fatty acid profile between hypertensive and
normotensive participants
Difference in individual FA between hypertension pa-
tients and normotensive persons was presented in
Table 2. Compared with normotensive participants,
hypertension patients had significantly higher propor-
tions of serum 14:0, 16:0, 18:0, 22:0,16:1n-7, 18:1n-9,
18:3n-6, 20:3n-6 and Δ6-desaturase index (18:3n-6/
18:2n-6) as well as lower 18:2n-6, 22:6n-3 and Δ5-desa-
turase index (20:4n-6/20:3n-6) (P < 0.05, respectively). In
addition, lower proportions of total n-3 PUFA, total
PUFA and n-3/n-6 ratio as well as higher total SFA and
SFA/PUFA ratio in serum were observed in the hyper-
tension patients than in the normotensive participants
(P < 0.05, respectively).
Factor analysis of individual FA
Serum compositions of individual FA and rotated factor
loadings of the extracted FA-factors were presented in
Table 3. The two major FA-factors can be interpreted as
a reflection of serum FA patterns, which explained about
68.73 % of individual FA-related variance. Factor 1 as
the most powerful factor (eigenvalue = 3.20), termed
“low linoleic acid (LA)/high SFA pattern”, comprised a
strongly negative loading from 18:2n-6 (linoleic acid)
and higher positive loadings from14:0, 16:0, 16:1n-7,
18:1n-9 and 18:3n-6. These non-essential FA can be syn-
thesized endogenously in response to a high intakes of
saturated fat. [8] Factor 2 was defined as “n-3 PUFA pat-
tern” (eigenvalue = 1.95), which mainly comprised higher
positive loadings from 20:5n-3, 22:5n-3 and 22:6n-3 as
well as a strongly negative loading from 18:1n-9.
Serum FA pattern and BP levels
Adjusted mean of SBP and DBP with 95 % CI by tertile
groups of the generated FA-factor scores was presented
in Table 4. After adjustment for age, gender, BMI, and
hypertension treatment, SBP and DBP levels were sig-
nificantly increased in participants in the upper tertiles
of Factor 1 scores (low LA/high SFA pattern: 14:0, 16:0,
16:1n-7, 18:2n-6, 18:3n-6) compared with those in the
bottom tertiles (P for trend = 0.006 and 0.019, respect-
ively). Additional adjustment for lifestyle factors (model 1)
did not obviously alter theses results (P for trend < 0.007
and = 0.038, respectively). Even after additional adjustment
for family history of hypertension, HR, TC, TG, Fbg levels
(model 2), the association remained significant, with each
a SD increment of Factor 1 score associated with an incre-
ment of 2.44 (95 % CI: 1.73, 3.15) mm Hg for SBP and
1.46 (95 % CI: 0.70, 2.22) mm Hg for DBP, respectively. By
contrast, participants in the upper tertiles of Factor 2
scores (n-3 PUFA pattern: 20:5n-3, 22:5n-3, 22:6n-3 and
18:1n-9) had significantly decreased DBP levels compared
with those in the bottom tertiles (P for trend = 0.026). The
association slightly attenuated but remain significant in
lifestyle-adjusted model 1 (P for trend = 0.042). The results
with additional adjustment for clinical factors in model 2
were similar to those of lifestyle-adjusted model 1 (P for
trend = 0.037), and per a SD increment of Factor 2 scores
was associated with a reduction of 1.40 (95 % CI: 0.80,
2.041) mm Hg for DBP.
The major individual FA and BP levels
Adjusted mean of SBP and DBP with 95 % CI by tertile
groups of individual FA composition in serum was pre-
sented in Additional file 1: Table S1. After controlling
for age, gender, BMI and hypertension treatment, SBP
and DBP levels significantly increased with increasing in
serum proportions of 16:0, 16:1n-7, 18:1n-9 and 18:3n-6
(all P for trend <0.05), whereas SBP significantly decreased
only with 18:2n-6 increasing (P for trend <0.001). De-
creased DBP levels were associated with increased
proportions of 20:5n-3 and 22:6n-3 (P for trend =
0.017 and 0.010, respectively). Additional adjustment
for smoking, drinking, high-salt diet, education and
profession (model 1) did not appreciably alter these
associations, except for 18:1n-9. The results with add-
itional adjustment for family history, TC, TG, HR and
Fbg levels (model 3) were similar to those of model 2. A
significant positive association of SBP was observed with
16:0, 16:1n-7 and 18:3n-6 (P for trend = 0.034, 0.006 and
0.024, respectively), whereas an inverse association was
observed for 18:2n-6 (P for trend = 0.021). Both SBP and
DBP levels were significantly decreased in participants
with the top tertiles of 22:6n-3 compared with those with
the bottom tertiles (P for trend = 0.032 and 0.024,
respectively).
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Middle-age (≤ 55 y) 49.11 53.59 47.13
Elder (> 55 y) 50.89 46.41 52.87
Females 52.88 51.87 53.33 0.48
Education levels < 0.01
Primary (< 9 years) 66.89 75.61 62.31
Secondary (9–12 years) 27.86 21.41 31.25
High (>12 years) 5.25 2.98 6.44
Profession 0.01
Manual labor 38.66 34.24 40.64
non-manual labor 61.34 65.76 59.36
Lifestyle factors, %b
Smoking habit 0.01
Current smokers (≥ 18 pack/year) 24.28 20.94 25.75
Former/never 75.72 79.06 74.25
Drinking habit 0.04
Current (≥ 25 g/day) 26.86 25.13 28.62
Former/never 73.14 74.87 71.38
Salt consumption 0.01
High-salt (> 6 g/day) 25.72 29.21 24.18
Moderate/low-salt 74.28 70.79 76.82
Exercise habit < 0.01
Regular (≥ 3 times/week) 23.85 20.76 28.95
Irregular/never 76.15 79.24 71.05
Family history of hypertension, %b
Yes 24.43 34.46 20.99 < 0.01
No 75.57 65.54 79.01
Anthropometry indicators, mean (SD)c
BMI (kg/m2) 23.80 (3.23) 24.93 (3.43) 23.44 (3.18) < 0.01
SBP (mm Hg) 126.42 (17.95) 137.10 (12.76) 119.44 (14.78) < 0.01
DBP (mm Hg) 81.22 (7.53) 86.28 (8.66) 79.70 (6.10) < 0.01
HR (beat/min) 71.00 (10.19) 72.88 (11.07) 70.53 (9.75) < 0.01
Biochemical parameters, median (QR)d
TG(mmol/L) 1.26 (0.88–1.86) 1.47 (1.01–2.08) 1.19 (0.83–1.73) < 0.01
TC (mmol/L) 4.59 (4.07–5.24) 4.73 (4.19–5.35) 4.54 (4.02–5.85) < 0.01
Fbg (mmol/L) 4.64 (4.29–5.08) 4.73 (4.36–5.22) 4.60 (4.24–5.00) < 0.01
SD standard deviation, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, QR quartile range, TG triglyceride, TC total
cholesterol, Fbg fasting blood-glucose
aP value for significance between hypertensive and normotensive group with Student’s unpaired ttest and chi-square test, respectively
bCategorical data are presented as a percentage (%)
cContinuous data with a normal distribution are presented as mean (standard deviation)
dThe skewed data were expressed as the median (quartile range), and were log-transformed before statistic analyses
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Discussion
In the present study, serum FA profile in hypertensive par-
ticipants has been found to be typically characterized by
higher 14:0, 16:0, 16:1n-7, 18:3n-6, 20:3n-6 and Δ6-desa-
turase index (18:3n-6/18:2n-6) as well as lower 18:2n-6,
22:6n-3 and Δ5-desaturase index (20:4n-6/20:3n-6) com-
pared with normotensive participants. Factor analyses
showed that Factor 1 (low LA/high SFA pattern: 14:0,
16:0, 16:1n-7, 18:3n-6, 18:2n-6) and Factor 2 (n-3 PUFA
pattern: 20:5n-3, 22:5n-3, 22:6n-3, 18:1n-9) were identified
as an indicator of the serum FA pattern. Serum low LA/
high SFA pattern was adversely associated with both SBP
and DBP, whereas n-3 PUFA pattern was beneficially asso-
ciated with DBP. These associations cannot be apparently
altered even after adjustment for age, gender, BMI, hyper-
tension, lifestyle and clinical factors. Such findings further
build and extend on the relationship between serum FA as
biomarker and BP levels in Chinese.
A prior cross-sectional study of 1081 urban Italian
women aged 20–69 years [18] and a large prospective
cohort study of 4652 subjects aged 35–63 years from
France [19] suggested that no significant association was
found between intake of n-3 PUFA and BP levels. A pos-
sible explanation would be underestimated association
due to diet assessment errors and recall bias during a
dietary questionnaire. In contrast, circulating levels of
individual FA can reflect both dietary consumption and
relevant biological processes, which can be regarded as a
helpfully complementary tool for food frequency ques-
tionnaire (FFQ) to closely assess diet intakes. Previous
studies of FA biomarkers suggested that increased BP
levels were associated with a high content of SFA and
low n-3 PUFA in blood [11, 20, 21]. Nevertheless, to
date, data of serum/plasma FA in relation to BP levels of
individuals are scarce in China. Accumulating evidence
has showed that a serum FA pattern characterized by
Table 2 Serum fatty acid profile between hypertensive and normotensive participants
FA (%) Hypertensive (n = 748) Normotensive (n = 1699) P valuea
Mean/Median SD/QR Mean/Median SD/QR
14:0 1.61 1.40–1.80 1.56 1.29–1.74 0.033
16:0 20.62 2.60 21.05 2.57 <0.001
18:0 6.40 0.85 6.34 0.78 0.036
20:0 0.48 0.30–0.73 0.51 0.20–0.85 0.148
22:0 0.55 0.33–1.43 0.44 0.27–1.27 0.012
24:0 0.39 0.31–0.42 0.40 0.27–0.45 0.127
16:1n-7 1.69 0.82 1.52 0.78 <0.001
18:1n-9 19.98 3.75 18.95 3.75 <0.001
24:1n-9 1.20 0.92–1.34 1.18 0.82–1.22 0.121
18:3n-3 0.94 0.37 0.93 0.41 0.058
20:5n-3 3.31 1.55 3.35 1.60 0.436
22:5n-3 0.47 0.38–0.58 0.46 0.38–0.56 0.528
22:6n-3 1.65 0.51 1.74 0.69 0.005
18:2n-6 27.40 5.21 28.52 5.28 <0.001
18:3n-6 0.36 0.25–0.51 0.32 0.20–0.46 <0.001
20:3n-6 1.16 0.32 1.13 0.31 0.018
20:4n-6 6.04 1.56 6.01 1.62 0.120
20:4n-6/20:3n-6 5.20 0.87 5.66 0.96 <0.001
18:2n-6/18:3n-6 (×10−2) 1.34 0.84–2.05 1.13 0.73–1.77 <0.001
SFA 30.69 3.25 28.87 2.62 <0.001
MUFA 21.38 4.26 21.25 4.44 0.504
PUFA 42.25 4.43 43.66 5.41 <0.001
n-3 PUFA 6.17 5.60–7.04 6.28 5.48–7.30 0.024
n-6 PUFA 36.04 5.00 37.37 4.60 0.010
n-3/n-6 0.15 0.13–0.19 0.16 0.13–0.23 0.031
SFA/PUFA 0.81 0.63–0.92 0.68 0.60–0.82 <0.001
QR quartile range, SFA saturated fatty acid, MUFA monounsaturated fatty acid, PUFA polyunsaturated fatty acid
aP value for difference between groups was tested by an unpaired t-test
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high proportions of 16:0, 16:1n-7, 20:3n-6 and low
18:2n-6 was associated with stroke [22] and left ven-
tricular hypertrophy [23]. In agreement with the previ-
ous findings, we found that the serum low LA/high SFA
pattern was strongly associated with increased SBP. It is
known that dyslipidemia and BMI were associated with
greater BP levels [24, 25]. Increased levels of blood TG
can damage endothelial function mediated by nitric
oxide production as well as accelerate structural changes
in large arteries [26]. A higher BMI can increase BP
through elevated cardiac output, expanded blood vol-
ume, and boosted peripheral vascular resistance [27].
However, the positive association of low LA/high SFA
pattern with BP levels did not apparently altered even
after additional adjustment for these cardiometabolic
risk factors in the present study. Accordingly, we specu-
lated that the adverse effects might be attributable to the
main contribution made by individual 16:0, 16:1n-7 and
18:3n-6. The multivariable analysis of tertile groups of
individual FA showed that SBP levels trend to increase
as increasing in serum composition of 16:0, 16:1n-7 and
18:3n-6, which was concordant with results from many
investigators of circulating individual FA in relation to
BP [9, 10, 28]. Serum SFA and MUFA may be highly
correlated with dietary intakes of saturated fat in persons
that consumed a high-SFA diet [7]. Circulating levels of
18:3n-6 trend to increase on a high-SFA diet, possibly
because dietary saturated FA can influence enzymes in-
volved in its metabolism [29]. Thus, the serum FA pat-
tern characterized by high 16:0, 16:1n-7, 18:3n-6 and
20:3n-6 as well as low 18:2n-6 perhaps reflected a diet
high in saturated fat relative to polyunsaturated fat in
this middle-aged and elderly Chinese population.
Current American Heart Association dietary guidelines
for CVD prevention in the community recommends an
increase in both n-6 and n-3 PUFA consumption to-
gether with a reduction in SFA. A cross-sectional study
conducted in Guangzhou, China has reported that
erythrocyte compositions of long-chain n-3 PUFA was
associated with reduction of BP levels in a general
Chinese population [12]. In line with the study, our data
indicated that participants in the upper tertiles of serum
22:6n-3 had significantly decreased BP levels compared
with those in the bottom tertiles, which cannot be al-
tered even by multiple adjustments. We therefore still
suggest that higher intakes of food n-3 FA will increase
exposure in vivo, which can favorably influence BP levels
for Chinese persons. Nevertheless, the beneficial impacts
by serum n-3 PUFA pattern were not observed on SBP
levels with additional adjustment for possible con-
founders. We also found that no significant association
of BP with individual 18:1n-9 in the multivariate-
adjusted model. Thus, a possible explanation was that
the lower-SBP effects by n-3 PUFA may be offseted by a
strongly negative determinant from 18:1n-9 in n-3 PUFA
factor. These observed associations together support that
the key to dietary fat consumption benefits for BP levels
lies not only in supplementations of its quantity, but also
in the improvement in its quality.
There is a large number of evidence to suggest that
the opposing effects of dietary saturated fat and polyun-
saturated fat on BP levels. Dietary saturated fat can ad-
versely influence BP levels by increasing oxidative stress
and decreasing nitric oxide (NO) production within the
endothelium [30]. Alterations in the metabolism of
PUFAs might be a predisposing factor to the develop-
ment of essential hypertension [31–33]. A case-control
study of plasma phospholipids FA profile analysis re-
vealed that higher 16:0, 18:0, 18:3n-6 and lower 18:2n-6
were found in hypertensive patients compared to normal
controls [33]. Similar to results from the study, a signifi-
cant difference in serum FA profile was found between
hypertensive and normotensive individuals in the
present study, and we also found that Δ6-desaturase
index was markedly higher, but Δ5-desaturase index was
lower in hypertension patients compared with normo-
tensive persons, suggesting that essential FA and their
Table 3 Serum proportions of individual fatty acid and varimax
rotation loadings of the major FA-factors
Fatty acid (FA) Proportionsa Factor 1 Factor 2
14:0 1.69 (1.43–1.95) 0.39b −0.06
16:0 20.76 (2.60) 0.64b −0.04
18:0 6.42 (0.89) 0.10 0.13
20:0 0.45 (0.29–0.73) −0.04 0.29
22:0 0.41 (0.25) −0.28 0.01
24:0 0.36 (0.11) −0.26 0.13
16:1n-7 1.59 (0.84) 0.79b 0.16
18:1n-9 19.30 (3.83) 0.35 −0.46c
24:1n-9 1.04 (0.76–1.38) −0.02 −0.02
18:2n-6 28.26 (5.31) −0.86b −0.19
18:3n-6 0.34 (0.22–0.48) 0.46b 0.31
20:3n-6 1.14 (0.31) 0.39b 0.29
20:4n-6 6.02 (1.61) −0.25 0.37
18:3n-3 0.93 (0.37) 0.17 −0.23
20:5n-3 3.25 (1.23) 0.03 0.55c
22:5n-3 0.51 (0.24) 0.31 0.44c
22:6n-3 1.73 (0.62) −0.20 0.56c
Eigenvalue 3.20 1.95
The proportion of total variance (%) 44.13 25.60
aData with a normal distribution are presented as mean (standard deviation),
while the skewed data were expressed as the median (quartile range)
bValues in boldface were major factor loadings that contribute to identify
Factor 1
cValues in boldface were major factor loadings that contribute to identify
Factor 2
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Table 4 Adjusted blood pressure mean with 95 % confidence interval by tertiles of FA-factor scores in 2447 individuals
Factor scores
(Dominant FA)
n Adjusted SBP Mean (95 % CI) Adjusted DBP Mean (95 % CI)
Initial modela Model 1b Model 2c Initial modela Model 1b Model 2c
Factor 1(14:0, 16:0, 16:1n-7, 18:2n-6, 18:3n-6, 20:3n-6)
T1 (<−0.46) 832 123.51 (123.07, 124.00) 123.48 (122.97, 124.01) 123.80 (122.26, 124.33) 80.30 (80.12, 80.57) 80.22 (79.85, 80.49) 80.33 (80.06, 80.61)
T2 (−0.46–0.30) 783 126.81 (126.31, 127.39) 126.89 (126.34, 127.45) 127.30 (126.30, 127.91) 81.23 (80.02, 81.44) 81.34 (81.07, 81.69) 81.60 (81.30, 81.89)
T3 (≥ 0.30) 832 130.33 (129.81, 130.88) 130.55 (129.98, 132.23) 131.11 (130.48, 131.75) 82.12 (81.81, 82.33) 82.24 (81.98, 82.54) 82.58 (82.27, 82.98)
P for trendd 0.006 0.007 0.016 0.019 0.038 0.030
Factor 2 (20:5n-3, 22:5n-3, 22:6n-3, 18:1n-9)
T1 (<−0.35) 831 129.72 (129.17, 130.26) 128.05 (127.46, 128.62) 127.80 (127.28, 128.32) 82.25 (82.05, 82.44) 82.27 (82.02, 82.53) 82.99 (82.59, 83.20)
T2 (−0.45–0.38) 807 126.87 (126.28, 127.45) 126.57 (126.01, 127.12) 126.43 (125.94, 126.92) 81.05 (80.86, 81.24) 81.03 (80.78, 81.29) 81.24 (80.95, 81.53)
T3 (≥ 0.38) 809 125.87 (125.34, 126.40) 126.36 (125.81, 126.90) 126.40 (125.91, 126.88) 80.12 (80.05, 80.34) 80.46 (80.20, 80.72) 79.84 (79.29, 80.35)
P for trendd 0.101 0.782 0.804 0.026 0.042 0.037
FA fatty acid, n number of subjects, SBP systolic blood pressure, DBP diastolic blood pressure, CI confidence interval, T3 the upper tertiles, T1 the bottom tertiles
aInitial model was adjusted for age, gender, BMI and hypertension
bModel 1 was adjusted for covariates in the initial model plus smoking, alcohol intake, education, profession, exercise, and salt intake
cModel 2 was adjusted for covariates in the model 1 plus family history, heart rate, triglyceride, total cholesterol and fasting blood-glucose level















metabolites may play an important role in the pathobiol-
ogy of hypertension [34]. Our study indicated that the
hypertensive patients consumed lower 18:2n-6 than nor-
mal, which was supported by a study by McCarron et al
[35]. 18:2n-6 can be converted to 18:3n-6 by Δ6-desatur-
ase in human body, which may be modified by dietary
nutrients (e.g., magnesium) as cofactors [32]. 20:5n-3
can block the activity of Δ5-desaturase such that 20:4n-6
levels in tissue will be low. 20:4n-6 can form the precur-
sor of 2-series of PGs that stimulates vascular constric-
tion and smooth muscle contraction, whereas 20:5n-3 is
precursor of PGI3 and thromboxane A3 that have been
reported to be less active. Thus, increased consumption
of marine food rich in 20:5n-3 and 22:6n-3 can competi-
tively inhibit hepatic Δ5-desaturase to reduce circulating
levels of metabolites from 20:4n-6 such as PGF2aand
thromboxane A2 [36]. Possible mechanisms whereby n-3
FA may favorably influence BP may be multifactorial in-
volving improvements in endothelial vasodilator func-
tion [37, 38], reactivity of resistant vessel vascular
smooth muscles [39] and arterial compliance [40], along
with a cardiac effect mediated by a decrease in heart rate
to provide an energy-sparing promotion of diastolic re-
laxation [41]. In addition, BP and cardiac β-adrenergic
receptor responsiveness decreased on a low-fat diet with
a high ratio of PUFA/SFA (P/S) [42]. However, the P/S
ratio and total dietary fat are often altered in diet, and
thus the oppositive mechanisms between saturated fat
and polyunsaturated fat have not yet been understood
and remain to be further elucidated.
Dietary nutrients as cofactors are necessary for the for-
mation of potent platelet anti-aggregators and vasodila-
tors such as prostaglandin E1 (PGE1) and PGI3, which
can prevent the development of hypertension [32].
Lower magnesium can reduce the Δ 6-desaturase activ-
ity, leading to an inadequate the conversion of 20:3n-6
to PGE1 [43]. Vitamin C can improve nitric oxide (NO)
production and enhance the synthesis of PGE1 in hyper-
tension [44, 45]. Many studies found that higher intake
of salt can lead to BP, but sodium seems to act in con-
cert with other nutrients such as calcium, potassium,
magnesium, vitamin C, and antioxidants present in fruits
and vegetables act together to determine the ultimate
degree of BP by regulating the release of PGE1, PGI2
and NO production [32, 46]. We found that higher in-
take of salt was present in hypertension patients com-
pared with normotensive participants, which was
supported by the observation that plasma NO levels de-
creased in patients with hypertension after salt loading
[47], suggesting that excess salt intake can reduce NO
production from the endothelial cells in patients with
salt-sensitive hypertension. However, we was unable to
exclude the effects of total energy intake or the con-
sumption of PUFAs, saturated fats, trans-fats and other
food nutrients on BP in the study population, as dietary
intakes were not assessed at baseline. A dietary survey of
middle-aged nutrient intake in East (China and Japan)
Asian and Western (UK and US) persons revealed that
Chinese sample population has lower intake of total fat,
saturated fat, trans-fatty acid, potassium, vitamin C and
calcium as well as higher sodium and sodium/potassium
ratio compared to western persons, whereas no marked
difference in dietary intake of magnesium were found
between the two populations [48]. In addition, peroxida-
tion of unsaturated FA such as 18:3n-3 can result in the
formation of aldehydes such as 4-hydroxypentenal caus-
ing both hypertension and oxidative stress. Superoxide
anion can inactivate PGI2 and NO [49], which can lead
to elevated BP by an increase in peripheral vascular re-
sistance. Evidence indicated that the superoxide dismut-
ase activity and vitamin E concentration were found to
be lower, whereas plasma superoxide anion and lipid
peroxides were found to be higher in patients with un-
controlled hypertension [44, 50]. Thus, the interaction
among free-radical, NO, PUFAs, antioxidants and other
dietary nutrients on BP in the study population may be
helpful for understanding the aetiopathogenesis of
hypertension, but its mechanism is presently unclear
[51, 52]. Further studies were merited to clarify the bio-
logical plausibility related to PUFAs interaction with free
radicals, NO and other nutrients in the development of
hypertension.
Many a strengths should be highlighted in our
study. Firstly, we used a method of exploratory factor
analyses to identify the major FA-factors as indicators
of serum FA patterns, facilitating the interpretation of
the findings. Additionally, the amount of exogenous
and endogenous FA can be closely represented by
serum FA, independent of diet records and recalls
bias. However, the potential limitations were likely to
bias the endings. Firstly, the causal relations cannot
be determined. Secondly, we cannot affirm that a
dietary pattern of low LA/high SFA can unfavorably
influence BP levels, because data are lacking on food
FA and BP. Thirdly, the part of the positive associ-
ation between BMI and BP may depend on dietary fat
intakes, considering that BMI is a strong determinant
of BP levels. It may be questioned whether controlling
for BMI in the multivariate model is appropriate
when assessing the strength of the linear association.
Fourthly, all participants were recruited from the
communities in Zhejiang province located in south-
east China, which did not perfectly represent a ran-
dom sample of a general Chinese population. Thus,
caution is required in generalizing the current results
to the whole middle-aged and elderly Chinese. Fifthly,
participants with prevalent hypertension were identi-
fied by self-reported information on anti-hypertensive
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drugs use, which might be subject to report bias.
Sixthly, the clear association between FA-factors and
BP can be drawn in the present study, possibly be-
cause limited community-dwellers living in the same
regions are those who have a similar life style. Thus,
it is necessary to further demonstrate whether these
effects of individual FA on BP can be general in
Chinese adults. Finally, we cannot exclude the possi-
bility that the unknown or incompletely measured
valuables modified the findings.
Conclusions
In conclusion, the serum FA pattern characterized by
low proportions of 16:0, 16:1n-7 and 18:3n-6 as well as
high 18:2n-6 and 22:6n-3 was associated with reduced
BP levels in this middle-aged and elderly Chinese popu-
lation. Such evidence well supports the current dietary
recommendations in the communities to replace satu-
rated fat with polyunsaturated fat. A well-designed co-
hort study is further needed to prospectively confirm the
effects of individual FA in circulating blood on BP levels
in a larger Chinese population.
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